$Annovis Bio (ANVS.US)$ Annovis Bio Announced The Completion...
$Annovis Bio(ANVS.US$ Annovis Bio Announced The Completion Of Data Cleaning For Its Phase 2/3 Study Of Buntanetap In Patients With Mild To Moderate Alzheimer's Disease. Topline Efficacy Data Is Expected In April
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment